Comprehensive Mind Map of Ischemic Stroke
I. DEFINITIONS & CLASSIFICATION
Ischemic stroke is defined as focal brain injury with symptoms lasting >24 hours or imaging evidence of acute infarction, while TIA represents transient neurological dysfunction from focal brain/spinal cord/retinal ischemia without acute infarction 1.
Stroke Subtypes by Mechanism 1, 2:
- Large-artery atherosclerosis (20%): Extracranial or intracranial carotid/vertebrobasilar disease
- Cardioembolic (20%): Most commonly from atrial fibrillation
- Small-vessel disease (25%): Lacunar/subcortical strokes from penetrating artery disease
- Other determined causes: Dissection, hypercoagulable states, sickle cell disease
- Cryptogenic (30%): Undetermined cause despite workup
II. RISK FACTORS
A. Non-Modifiable Risk Factors 3, 2:
- Age: Risk increases exponentially with advancing age
- Sex: Women experience 60,000 more strokes annually than men
- Race/Ethnicity:
- American Indian/Alaskan Native: 6.7% prevalence (highest)
- Black men and women: 4.0% prevalence (twice that of whites)
- Hispanic/Latino: 3.1% men, 1.9% women
- Prior TIA: 90-day stroke risk up to 17%, greatest in first week 1
- Genetic factors
B. Modifiable Risk Factors 1, 4:
Hypertension (Most Important):
- Present in 72 million Americans (SBP ≥140 or DBP ≥90 mmHg)
- Continuous association with stroke risk starting at SBP 115 mmHg
- BP lowering reduces stroke risk by 30-40% 1
Other Major Modifiable Factors:
- Diabetes mellitus
- Atrial fibrillation
- Dyslipidemia
- Cigarette smoking
- Physical inactivity
- Obesity
- Excessive alcohol consumption
- Carotid stenosis
- Left ventricular hypertrophy
III. PATHOPHYSIOLOGY 5:
The ischemic cascade involves multiple interconnected mechanisms:
- Energy deficiency: Loss of ATP production
- Ion homeostasis disruption: Calcium influx, sodium/potassium imbalance
- Oxidative stress: Free radical generation
- Neuroinflammation: Microglial activation, cytokine release
- Blood-brain barrier disruption: Vasogenic edema
- Programmed cell death: Apoptosis, necrosis, autophagy
- Cerebral edema: Cytotoxic and vasogenic components
IV. CLINICAL PRESENTATION
Acute Symptoms (Depend on Vascular Territory):
- Sudden onset focal neurological deficits
- Hemiparesis/hemiplegia
- Facial droop
- Speech disturbances (aphasia, dysarthria)
- Visual field defects
- Sensory loss
- Ataxia/coordination problems
- Altered consciousness (in severe cases)
Critical Time Point:
"Last known well time" is the single most important determinant of treatment eligibility 2
V. DIAGNOSTIC WORK-UP
A. Immediate Imaging 6, 1:
For IV tPA candidates (0-4.5 hour window):
- Noncontrast CT OR MRI (DWI, FLAIR, GRE/SWI) to exclude hemorrhage and assess ischemic extent
For endovascular therapy candidates:
- Vascular imaging strongly recommended: CTA, MRA, or conventional angiography during initial evaluation 6
MRI with DWI is the most sensitive imaging technique for early ischemic changes 7
B. Minimum Required Evaluation 1:
- Brain imaging (CT or MRI) to distinguish ischemic from hemorrhagic stroke
- Vascular imaging of head and neck to evaluate mechanism and future risk 6
- Evaluation to exclude high-risk conditions:
- Carotid stenosis
- Atrial fibrillation
- Echocardiography for cardiac sources
VI. ACUTE MANAGEMENT
A. Blood Pressure Management 8, 9:
For patients NOT receiving reperfusion therapy:
- Do NOT actively lower BP if <220/120 mmHg in first 48-72 hours (not effective for preventing death/dependency)
- Spontaneous BP lowering occurs in ~75% of patients naturally 8
For IV thrombolysis candidates:
- Pre-treatment target: <185/110 mmHg
- Maintain <180/105 mmHg during first 24 hours 8
- Post-thrombolysis: Maintain SBP 140-180 mmHg (reduces ICH without improving outcomes at lower targets) 8
For endovascular therapy candidates:
- Pre-procedure: <185/110 mmHg 8
- Post-EVT: Avoid intensive lowering to <140 mmHg (leads to lower functional independence and higher mortality) 8
B. Reperfusion Therapy:
IV Thrombolysis (rtPA/Alteplase):
- 0-4.5 hour window from last known well time
- Requires BP <185/110 mmHg before treatment 8
Endovascular Therapy (Mechanical Thrombectomy):
- Extended time windows (up to 8+ hours with appropriate imaging selection)
- Requires vascular imaging to confirm large vessel occlusion 6
C. Early Mobilization 10:
Graduated early mobilization initiated between 24-48 hours post-stroke is recommended 10
AVOID very early mobilization (<24 hours):
- Associated with decreased odds of favorable 3-month outcomes
- Especially harmful in patients with:
- Worse NIHSS scores
- Intracerebral hemorrhage
- Impaired consciousness
- Higher intensity/frequency sessions 10
VII. SECONDARY PREVENTION
A. Blood Pressure Control 1, 9:
Long-term target: <130/80 mmHg 9
- Greater BP reductions = greater stroke risk reduction
- No clear drug class-specific advantage 1
Preferred agents:
- Thiazide diuretics
- ACE inhibitors
- Angiotensin receptor blockers
- Calcium channel blockers 9
B. Antiplatelet Therapy 11:
For noncardioembolic stroke:
- Dual antiplatelet therapy (aspirin + clopidogrel) for 21-90 days for minor strokes and high-risk TIA
- Convert to single antiplatelet therapy after initial period 11
For cardioembolic stroke:
- Long-term anticoagulation required
- Direct oral anticoagulants (DOACs) preferred over warfarin for nonvalvular atrial fibrillation 11
C. Lipid Management:
- Statin therapy for atherosclerotic disease
- Target LDL reduction
D. Diabetes Management:
- Glycemic control optimization
E. Lifestyle Modifications 1, 4:
- Weight loss if overweight
- Diet rich in fruits, vegetables, low-fat dairy
- Regular aerobic physical activity
- Limited alcohol consumption
- Smoking cessation
F. Carotid Revascularization:
- For significant carotid stenosis (≥50-70% symptomatic)
VIII. COMPLICATIONS
Acute Phase (First 72 hours) 2:
- Cerebral edema
- Hemorrhagic transformation
- Seizures
- Aspiration pneumonia
- Deep vein thrombosis
- Pressure ulcers
- Neurological deterioration
Chronic Sequelae 11:
- Mobility/balance impairments
- Cognitive deficits
- Dysphagia
- Poststroke depression (common and undertreated)
- Chronic pain
- Spasticity
IX. REHABILITATION 10, 11:
Multidisciplinary approach is essential:
A. Physical Therapy:
- Mobility training
- Balance exercises
- Gait training
- Strength building
B. Occupational Therapy:
- Activities of daily living retraining
- Adaptive equipment training
- Upper extremity function
C. Speech Therapy:
- Aphasia treatment
- Dysphagia management
- Cognitive-communication therapy
D. Prevention of Complications 10:
- Regular skin assessments using valid measurement instruments during acute hospitalization and post-acute care
- Positioning protocols
- Early mobilization (24-48 hours)
- Contracture prevention
E. Psychosocial Support:
- Depression screening and treatment
- Caregiver education
- Community reintegration planning
X. PHASES OF CARE 2:
Phase 1 (Hyperacute/Emergency): 0-24 hours
- Identify stroke symptoms and location
- Determine last known well time
- Assess for reperfusion therapy eligibility
- Initiate acute treatment
Phase 2 (Acute): 24-72 hours
- Clarify stroke mechanism
- Prevent medical complications
- Begin secondary prevention
- Prepare for discharge planning
Phase 3 (Subacute/Rehabilitation): Beyond 72 hours
- Intensive rehabilitation
- Optimize secondary prevention
- Address chronic complications
- Long-term follow-up
XI. CRITICAL PITFALLS TO AVOID
- Delaying imaging: Time is brain—immediate CT/MRI is mandatory
- Aggressive BP lowering in acute phase: Harmful unless >220/120 mmHg or receiving reperfusion therapy 8
- Very early mobilization (<24 hours): Associated with worse outcomes 10
- Missing atrial fibrillation: Requires anticoagulation, not antiplatelet therapy
- Inadequate long-term BP control: Target <130/80 mmHg for secondary prevention 9
- Undertreating depression: Common and significantly impacts recovery 11
- Premature discontinuation of dual antiplatelet therapy: Continue for full 21-90 days in appropriate patients 11